[Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
作者信息
Persson I, Ulrich J
出版信息
Ugeskr Laeger. 1973 May 17;135(20):968-70.
PMID:4755952
Abstract
摘要
相似文献
1
[Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
Ugeskr Laeger. 1973 May 17;135(20):968-70.
2
[The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
Orv Hetil. 1976 Mar 7;117(10):593-8.
3
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
Eur J Clin Pharmacol. 1973 Dec;6(4):217-9. doi: 10.1007/BF00644734.
4
[Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
Ugeskr Laeger. 1973 May 17;135(20):971-4.
5
Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
Curr Ther Res Clin Exp. 1975 Sep;18(3):387-94.
6
Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
N Z Med J. 1974 Aug 28;80(522):151-7.
7
8
[Utilization of pindolol in arterial hypertension. Study during rest and during effort].
Nouv Presse Med. 1978 Sep 20;7(31):2783-4.
9
[Antihypertensive properties of a beta blocking agent, pindolol].
Nouv Presse Med. 1973 Nov 10;2(40):2685-8.
Zotero 插件